×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Coronavirus | Coronavirus Special | Financial Markets | Health Topics | Vaccines | Cold/Flu | celltrion

Celltrion Trial Shows COVID Antibody Treatment Safe, Effective

a website for celltrion is showing with a magnifying glass highlighting the logo
(Pavel Kapysh/Dreamstime)

Sunday, 13 June 2021 10:36 PM

South Korean drugmaker Celltrion Inc. on Monday announced positive results for its experimental antibody COVID-19 treatment that it said was safe and reduced the treatment period by nearly five days in Phase 3 global clinical trials.

The trials, which involved 1,315 participants, have taken place since January in 13 countries, including in South Korea, the United States, Spain and Romania, Celltrion said in a statement.

The treatment slowed severe symptoms of COVID-19 in more than 70% of patients, including the high-risk group with underlying conditions. It also cut the recovery period by 4.9 days, the company said.

In February South Korea, granted conditional approval to the antibody treatment, making it the first locally made coronavirus treatment in the country to win such approval. The company said it would seek full authorization based on the trial results.

Celltrion shares rose as much as 5.6% in Monday morning trade, compared with a 0.3% drop in the wider market.

© 2021 Thomson/Reuters. All rights reserved.


SciTech
South Korean drugmaker Celltrion Inc. on Monday announced positive results for its experimental antibody COVID-19 treatment that it said was safe and reduced the treatment period by nearly five days in Phase 3 global clinical trials.
celltrion, treatment, antibody, drug, clinic, trial, safety, efficacy, covid-19, pandemic, south korea
156
2021-36-13
Sunday, 13 June 2021 10:36 PM
Newsmax Media, Inc.
More Articles
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved